170 results

• Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named

  March 27, 2025

  Irvin Jackson

  The federal judge overseeing all Valsartan lawsuits has approved a process that requires plaintiffs to establish they used specific versions of the recalled pills made by each manufacturer named as a defendant in their complaint.

• Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master

  March 4, 2025

  Irvin Jackson

  A Special Master has issued a schedule for preparing the first Valsartan bellwether lawsuit for trial later this summer.

• Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits

  February 20, 2025

  Irvin Jackson

  Plaintiffs and defendants behind nearly 1,300 Valsartan cancer lawsuits have filed dueling schedules for a second wave of bellwether trials, with plaintiffs seeking to hold one multi-plaintiff trial.

• Court Asked To Establish Valsartan Settlement Fund and Appoint Administrator

  January 23, 2025

  Irvin Jackson

  The judge presiding over the federal Valsartan lawsuits has been asked to approve the creation of a qualified settlement fund, as well as appoint an administrator and custodian for funds that will be paid to former users of the recalled hypertension drugs who have developed cancer.

• Five Valsartan Lawsuits Selected for Second Round of Bellwether Trials

  January 6, 2025

  Irvin Jackson

  A Special Master has ordered that five more Valsartan lawsuits be prepared for a second round of potential bellwether trials, to further test claims that the recalled blood pressure drugs caused users to develop cancer.

• Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for Trial September 8, 2025

  December 4, 2024

  Irvin Jackson

  The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.

• Valsartan Liver Cancer Lawsuit Selected for First Jury Trial in MDL

  October 28, 2024

  Irvin Jackson

  The first bellwether trial in the federal Valsartan MDL will involve claims brought by an Alabama man diagnosed with liver cancer, which is the injury most commonly reported among former users of the recalled blood pressure drug.

• Valsartan Cancer Lawsuits To Be Set for First Bellwether Trial, Instead of Third-Party Payor Claim

  October 22, 2024

  Irvin Jackson

  Following the postponement of a third party payor trial previously set to begin this month, the judge presiding over all valsartan lawsuits will hold a conference today with lawyers to discuss the selection of a cancer claim that will now be the first to go before a jury.

• FDA Finalizes Guidelines To Keep Cancerous Impurities Out of U.S. Medications

  September 12, 2024

  Irvin Jackson

  Federal regulators aim to eliminate nitrosamine contamination of generic drugs, which can increase the risk of cancer in patients taking them.

• Sanctions Imposed in Valsartan Recall Lawsuits Over Drug Maker’s Discovery Violations

  July 25, 2024

  Irvin Jackson

  A Chinese generic valsartan manufacturer has been fined more than 300,000 for failing to adhere to discovery requirements and make its CEO available for depositions.